Spirethoughts - Archive

Spire's past Spirethoughts appearances.

(English) Airlines caught in Covid turbulence
(English) M&A during Covid-19
(English) Oil markets drowning in glut as storage dwindles
(English) An agreement to boost trade between Indonesia and Australia
Cheaper and cleaner alternatives to coal electricity
(English) Cheaper and cleaner alternatives to coal electricity
(English) Countries fight Covid-19 crisis with economic bailout packag...

(English) Will electric cars be more enjoyable to drive?

The coronavirus has disrupted manufacturing in China and delivered a shock to global supply chains. One industry that is affected is pharmaceuticals.

China is a major production centre for active pharmaceutical ingredients or APIs.

Globally this has triggered concern. In India, pharma industry leaders have expressed concern that if disruption continues, pharma supply and prices would be affected. Market prices for anti-inflammatory drugs and antibioticsin India have risen sharply as a result of the crisis.

Will the coronavirus disrupt the global supply of pharmaceuticals?

For media enquiries, please contact:

Marie Teo
Manager, Group Marketing Communications
Spire Research and Consulting
Phone: (65) 6838 5355
E-mail: nidhi.singh@spireresearch.com

Back to Top

Back to Home